P3 Health Partners (PIII) Preferred Stock Liabilities (2019 - 2021)

P3 Health Partners has reported Preferred Stock Liabilities for 3 years, with the latest figure at $47.0 million in Q4 2021.

• For the quarter ending Q4 2021, Preferred Stock Liabilities changed N/A year-over-year to $47.0 million; the trailing twelve-month figure through Dec 2021 stood at $47.0 million (changed N/A YoY), and the FY2021 full-year result was $47.0 million, changed N/A from the prior year.
• Preferred Stock Liabilities for Q4 2021 stood at $47.0 million, up from $43.7 million in the prior quarter.
• The five-year high for Preferred Stock Liabilities was $47.6 million in Q4 2019, with the low at $43.7 million in Q4 2020.
• Historically, Preferred Stock Liabilities has averaged $44.9 million across 3 years, with a median of $43.7 million in 2020.
• The largest YoY upside for Preferred Stock Liabilities was 8.2% in 2020 against a maximum downside of 8.2% in 2020.
• P3 Health Partners' Preferred Stock Liabilities stood at $47.6 million in 2019, then slipped by 8.2% to $43.7 million in 2020, then increased by 7.75% to $47.0 million in 2021.
• The last three Preferred Stock Liabilities figures came in at $47.0 million (Q4 2021), $43.7 million (Q3 2021), and $43.7 million (Q2 2021), per Business Quant data.